Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 324.60
-3.00 (-0.92%)
May 13, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 10.22 billion as of May 13, 2025. Its market cap has decreased by -11.91% in one year.
Market Cap
10.22B
Enterprise Value
9.94B
Revenue
854.98M
Ranking
n/a
PE Ratio
75.00
Stock Price
324.60
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 10.22B, an increase of 2,650.86%. That is a compound annual growth rate of 30.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 103.52B |
| Sectra AB | 59.53B |
| Getinge AB | 52.98B |
| Medicover AB | 36.78B |
| Camurus AB | 36.68B |
| AddLife AB | 22.76B |
| Vitrolife AB | 21.41B |
| Vimian Group AB | 20.31B |